Abstract
The currently clinically available embolic agents face the huge challenges of incomplete vessel embolization, short blocking time, and high ectopic embolism risk. In article number 2011170, Lin Zhang, Jun Cao, Yourong Duan, and co-workers for the first time report a temperature-sensitive hydrogel to completely block mainstream and peripheral vessels with completely biocompatible pharmaceutical excipients and make a breakthrough in terms of largely reducing the ectopic embolism risk.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
